Literature DB >> 9433598

A Bayesian approach to multipoint mapping in nuclear families.

D C Thomas1, S Richardson, J Gauderman, J Pitkäniemi.   

Abstract

We describe the application of a Markov Chain Monte Carlo approach for multipoint mapping of a quantitative trait locus to the Nuclear Families simulated data. The method involves repeated sampling of genotype vectors for each nuclear family from their conditional distributions, given phenotypes, markers, and model parameters, using peeling and gene dropping, followed by random sampling of each model parameter given genotypes and the other parameters. Reversible jump methods are used to sample the number of trait loci.

Mesh:

Year:  1997        PMID: 9433598     DOI: 10.1002/(SICI)1098-2272(1997)14:6<903::AID-GEPI57>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  5 in total

1.  Performance of Markov chain-Monte Carlo approaches for mapping genes in oligogenic models with an unknown number of loci.

Authors:  J K Lee; D C Thomas
Journal:  Am J Hum Genet       Date:  2000-10-13       Impact factor: 11.025

2.  Bayesian model choice and search strategies for mapping interacting quantitative trait Loci.

Authors:  Nengjun Yi; Shizhong Xu; David B Allison
Journal:  Genetics       Date:  2003-10       Impact factor: 4.562

3.  Accounting for disease model uncertainty in mapping heterogeneous traits--a Bayesian model averaging approach.

Authors:  Swati Biswas; Charalampos Papachristou
Journal:  Hum Hered       Date:  2010-03-26       Impact factor: 0.444

4.  Bayesian model selection for genome-wide epistatic quantitative trait loci analysis.

Authors:  Nengjun Yi; Brian S Yandell; Gary A Churchill; David B Allison; Eugene J Eisen; Daniel Pomp
Journal:  Genetics       Date:  2005-05-23       Impact factor: 4.562

5.  Bayesian linkage analysis, or: how I learned to stop worrying and love the posterior probability of linkage.

Authors:  V J Vieland
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.